Actively Recruiting
Fr1da Early Diagnosis and Care of Type 1 Diabetes
Led by Helmholtz Zentrum München · Updated on 2024-12-17
285000
Participants Needed
1
Research Sites
721 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Fr1da study: "Early diagnosis and care of type 1 diabetes" aims to carry out a comprehensive, population-based screening for the early diagnosis of type 1 diabetes as part of the U7 to U11 preventive medical check-up for children or between the ages of 2 and 10 years in Bavaria and to implement it in other federal states. Screening is recommended at two time points: 1st screening at the age of 3 years (U7a) and 2nd screening at the age of 7 years (U10). In addition, relatives of patients with type 1 diabetes between the ages of 1 and 21 can be screened repeatedly at intervals of 3 to 5 years for an early-stage of type 1 diabetes.
CONDITIONS
Official Title
Fr1da Early Diagnosis and Care of Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent by one custodial parent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut für Diabetesforschung, Helmholtz Zentrum München
Munich, Germany
Actively Recruiting
Research Team
A
Anette-Gabriele Ziegler, Prof.Dr.med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here